Teleflex Incorporated (NYSE:TFX) Plans Quarterly Dividend of $0.34

Teleflex Incorporated (NYSE:TFX - Get Free Report) declared a quarterly dividend on Thursday, October 31st, Zacks reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.34 per share by the medical technology company on Monday, December 16th. This represents a $1.36 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Friday, November 15th.

Teleflex has a payout ratio of 8.8% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $15.41 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 8.8%.

Teleflex Stock Performance

Shares of NYSE:TFX traded up $10.15 during trading on Friday, hitting $211.21. The company's stock had a trading volume of 1,054,990 shares, compared to its average volume of 370,770. The company has a 50-day moving average of $240.17 and a 200-day moving average of $223.92. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. The firm has a market cap of $9.95 billion, a price-to-earnings ratio of 37.47, a P/E/G ratio of 2.13 and a beta of 1.16. Teleflex has a 12 month low of $190.49 and a 12 month high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to analysts' expectations of $768.68 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company's revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the company posted $3.64 EPS. On average, sell-side analysts expect that Teleflex will post 13.97 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on TFX shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Friday. Truist Financial raised their target price on shares of Teleflex from $247.00 to $255.00 and gave the stock a "hold" rating in a research note on Monday, October 14th. Royal Bank of Canada reduced their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research note on Friday. Mizuho lowered their price objective on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday. Finally, Stephens increased their target price on Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Teleflex presently has a consensus rating of "Moderate Buy" and an average price target of $262.75.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of the firm's stock in a transaction on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares in the company, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.43% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.